Navigation Links
Timing of HRT May Influence Heart Risks
Date:4/16/2008

Study found women with risk factors who took it early in menopause did not have diminished vessel function

WEDNESDAY, April 16 (HealthDay News) -- The timing of hormone therapy might determine its effect on a woman's heart.

Specifically, researchers have found that hormone replacement therapy (HRT) administered early in menopause to women with risk factors for heart disease did not diminish the function of the endothelial cells that line the inner walls of the arteries and might even improve it. Endothelial function is a way to measure early heart disease.

"Hormone therapy might not be as bad as was once thought," said Dr. Suzanne Steinbaum, director of Women and Heart Disease at Lenox Hill Hospital in New York City. "It might even be helpful in women with risk factors."

However, there isn't enough evidence to suggest that women should start taking HRT to lower their risk for heart disease, the authors emphasized.

The researchers, from Virginia Commonwealth University Medical Center in Richmond, presented their findings Wednesday at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology annual conference in Atlanta.

A section of the U.S. government-sponsored Women's Health Initiative (WHI), which was designed to look at health issues in postmenopausal women, was halted in 2002, when U.S. researchers found that hormone therapy led to an increased risk of adverse events that included heart attack, stroke, breast cancer and blood clots. The risk depended on whether the woman was taking estrogen alone or estrogen plus progestin, another female hormone.

Since that time, however, a more complex picture has emerged with various factors, including amount of hormone as well as timing, having an effect on risks and benefits of HRT.

Previous research indicated that HRT might have a negative effect on cardiovascular health in women who started therapy long after menopause, versus women taking it sooner after menopause.

Before the WHI, many women took HRT in the belief that it would reduce their risk for heart disease.

For this study, researchers used ultrasound to measure flow-mediated dilation (FMD) in the brachial artery in four groups of postmenopausal women (127 participants total).

FMD measures how well the endothelium functions. The brachial artery is the main artery in the arm.

"Endothelial dysfunction is often associated with risk factors," Steinbaum explained.

There were four groups in all: One comprised of women not on HRT, with no heart disease risk factors and about eight years postmenopausal; women not on HRT but who did have risk factors for coronary disease and a little over nine years postmenopausal; women taking estrogen alone, with risk factors and almost 12 years postmenopausal; and women taking estrogen plus progestin and 7.6 years postmenopausal.

Most women had started HRT about the time menopause started.

Women with risk factors who took HRT saw a slight improvement in FMD and, on the whole, there were no reductions in blood vessel function.

More information

Visit the Women's Health Initiative for more on hormone replacement therapy.



SOURCES: Suzanne Steinbaum, D.O., director, Women and Heart Disease, Lenox Hill Hospital, New York City; April 16, 2008, presentation, American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology annual conference, Atlanta


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. When It Comes to Pregnancy, Timing Is Everything
2. Communicating Clinical Trial Data: Timing Remains Key Challenge for Marketing Teams
3. Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
4. Appropriate timing in the use of breast shields in children can further reduce MDCT radiation dose
5. AUDIO from Medialink and AXA Equitable: Timing Retirement Thinking
6. T cell immunity enhanced by timing of interleukin-7 therapy
7. eDiets.com(R) Updates Timing of Third Quarter 2007 Earnings Conference Call
8. Newly Launched Regence Foundation to Help Transform Health Care and Influence the Nationwide Health Care Debate
9. Genes Influence on Fears Changes Over Time
10. Neighborhood Influences Exercise Levels
11. Prostate size and other neglected factors influence prostate cancer treatment satisfaction
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Timing of HRT May Influence Heart Risks
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
Breaking Medicine Technology: